| Metric | შპს Linema Pharm | სს თიბისი ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾3.9m₾1.6m | ₾2.11bn₾1.93bn |
| Revenue growth | 139.8% | 9.5% |
| Profitability | ||
| EBITDA | ₾1.2m₾465k | — |
| EBITDA margin | 31.0%28.7% | — |
| Net profit | ₾1.2m-₾90k | ₾1.12bn₾1.02bn |
| Net margin | 31.0%-5.5% | 53.0%53.1% |
| Balance sheet | ||
| Total assets | ₾7.5m₾6.2m | ₾31.77bn₾28.33bn |
| Total equity | ₾6.4m₾5.4m | ₾4.75bn₾4.27bn |
| ROE | 18.9%-1.6% | 23.6%24.0% |